Key result
Norepinephrine remains first-line for shock but requires standardized dosing and titration practices.
Why the study?
Despite the ubiquitous use of norepinephrine as the first-line vasopressor for shock, clinical practice regarding its administration remains heterogeneous.
This review provides practical guidance on the fundamentals of norepinephrine administration in critically ill patients with shock.
Answers are grounded in this paper and cite their sources.
Should not yet change shock protocols; leaves open need for prospective validation of norepinephrine strategies.
Current shock guidelines recommend norepinephrine as the first-line vasopressor to increase mean arterial pressure (MAP) and eventually restore tissue perfusion [1].Norepinephrine (or noradrenaline) is an endogenous catecholamine, produced both in postganglionic sympathetic nerves and adrenal glands.It became part of the therapeutic arsenal for the treatment of shock during the 1950s, gaining traction ever since.Despite its ubiquitous use throughout intensive care units (ICUs) and operating rooms worldwide [2], clinical practice related to its administration is still heterogeneous.We provide here a concise and practical article on the fundamentals of vasopressor administration in critically ill patients, using norepinephrine as a paradigmatic case example.
No takes yet. Share an insight, caveat, or question.
Kattan et al. (2024) conducted an editorial in Shock. Norepinephrine was evaluated. Norepinephrine remains the first-line vasopressor for shock, but significant heterogeneity exists in its dosing, formulation, and titration targets, highlighting the need for standardized practices.
Synapse has enriched 10 related papers. Consider them for comparative context: